Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)-Reference-Cited by-同舟云学术

Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)

Published:2017-03-17 Issue:7 Volume:215 Page:1085-1093
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Chi Heng,Hansen Bettina E.,Guo Simin,Zhang Ning Ping,Qi Xun,Chen Liang,Guo Qing,Arends Pauline,Wang Ji-Yao,Verhey Elke,de Knegt Robert J.,Xie Qing,Janssen Harry L. A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/215/7/1085/17412673/jix024.pdf

Reference37 articles.

1. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

2. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b;Gastroenterology,2008

3. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;HBV 99-01 Study Group; Rotterdam Foundation for Liver Research;Lancet,2005

4. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B;J Hepatol,2013

5. Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: a multicenter randomized trial (ARES study);ARES Study Group;Hepatology,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy;World Journal of Hepatology;2024-03-27

2. Combination treatment of pegylated interferon and tenofovir versus tenofovir for people with chronic hepatitis B;Cochrane Database of Systematic Reviews;2023-08-04

3. Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study;Canadian Journal of Gastroenterology and Hepatology;2022-12-07

4. The efficacy and safety of adding on or switching to peginterferon α‐2b in HBeAg‐positive chronic hepatitis B patients with long‐term entecavir treatment: a multicentre randomised controlled trial;Alimentary Pharmacology & Therapeutics;2022-09-20

5. The Pharmacologically Active Alkaloid Cryptolepine Activates a Type 1 Interferon Response That Is Independent of MAVS and STING Pathways;Journal of Immunology Research;2022-07-26